The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Akulov M.A.

FGBNU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Khat’kova S.E.

Federal state budgetary institution «Medical and Rehabilitation Center», Moscow

Orlova O.R.

Moskovskiĭ nauchno-prakticheskiĭ Tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia Moskvy, 119071, Moskva, Rossiĭskaia Federatsiia

Usachev D.Iu.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Zakharov V.O.

FGBNU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Orlova A.S.

I.M. Sechenov First Moscow State Medical University, Moscow

Tomskiĭ A.A.

FGBU "NII neĭrokhirurgii im. N.N. Burdenko" RAMN, Moskva

The efficacy of botulinum toxin therapy in patients with upper limb spasticity due to traumatic brain injury

Authors:

Akulov M.A., Khat’kova S.E., Orlova O.R., Usachev D.Iu., Zakharov V.O., Orlova A.S., Tomskiĭ A.A.

More about the authors

Read: 3980 times


To cite this article:

Akulov MA, Khat’kova SE, Orlova OR, Usachev DIu, Zakharov VO, Orlova AS, Tomskiĭ AA. The efficacy of botulinum toxin therapy in patients with upper limb spasticity due to traumatic brain injury. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(8):30‑35. (In Russ.)
https://doi.org/10.17116/jnevro20161168130-35

Recommended articles:
Effi­cacy of Reco­gnan in the therapy of neurological diso­rders after traumatic brain injury. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):41-45
Prevention of pathological skin scars (experimental study). Plastic Surgery and Aesthetic Medi­cine. 2025;(1):32-38

References:

  1. Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1691-1698. doi: 10.1212/01.wnl.0000311389.26145.95
  2. Brashear A. Spasticity: diagnosis and management. 2nd ed2016, New York: Demos Medical Publishing, LLC.
  3. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle & nerve. 2005;31(5):552-571.  doi: 10.1002/mus.20285
  4. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Katterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N. European consensus table on the use of botulinum toxin type A in adult spasticity. Journal of rehabilitation medicine. 2009;41(1):13-25.  doi: 10.2340/16501977-0303
  5. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818-1826. doi: 10.1212/wnl.0000000000002560
  6. Hat'kova SE, Orlova OR, Bocina AJu, Shihkerimov RK, Kovalenko AP. Osnovnye principy vedenija pacientov s narusheniem myshechnogo tonusa posle ochagovogo povrezhdenija golovnogo mozga. Consilium medicum. 2016;18(2.1):25-33. (In Russ.).
  7. Akulov MA, Orlova OR, Hat'kova SE, Usachev DJu, Zaharov VO, Tomskij AA, Orlova AS. Jelektromiograficheskij kontrol' pri provedenii in#ekcij botulotoksina tipa A v myshcy verhnej konechnosti pri spastichnosti razlichnoj jetiologii. Voprosy nejrohirurgii. 2015;6:38-45. (In Russ.).
  8. Yablon SA, Agana BT, Ivanhoe CB, Boake C. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial. Neurology. 1996;47(4):939-944. doi: 10.1212/wnl.47.4.939
  9. Pavesi G, Brianti R, Medici D, Mammi P, Mazzucchi A, Mancia D. Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury. Journal of neurology, neurosurgery, and psychiatry. 1998;64(3):419-420.  doi: 10.1136/jnnp.64.3.419
  10. O’Dell M, Brashear A, Walker H, Gul F, Edgley S, Wimmer M, Vilain C, Gracies J-M. AbobotulinumtoxinA (Dysport) in the treatment of adult patients with upper-limb spasticity due to traumatic brain injury. In American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly. Boston, MA, USA. 2015. doi: 10.1016/j.pmrj.2015.06.077
  11. Clemenzi A, Formisano R, Matteis M, Gallinacci L, Cochi G, Savina P, Cicinelli P. Care management of spasticity with botulinum toxin-A in patients with severe acquired brain injury: a 1-year follow-up prospective study. Brain injury. 2012;26(7-8):979-983.  doi: 10.3109/02699052.2012.660512
  12. Sendroy-Terrill M, Whiteneck GG, Brooks CA. Aging with traumatic brain injury: cross-sectional follow-up of people receiving inpatient rehabilitation over more than 3 decades. Archives of physical medicine and rehabilitation. 2010;91(3):489-497.  doi: 10.1016/j.apmr.2009.11.011
  13. Ovsjannikov DM, Chehonackij AA, Kolesov VN, Bubashvili AI. Social'nye i jepidemiologicheskie aspekty cherepno-mozgovoj travmy (obzor). Saratovskij nauchno-medicinskij zhurnal. 2012;8(3):777-785. (In Russ.).
  14. Ermolaev DO, Mordovcev AG, Ermolaeva JuN, Korolev IN. Social'nye aspekty cherepno-mozgovogo travmatizma. Uspehi sovremennogo estestvoznanija. 2007;1:63-64. (In Russ.).
  15. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. The Journal of head trauma rehabilitation. 2006;21(6):544-548.  doi: 10.1097/00001199-200611000-00009
  16. Poshataev KE. Jepidemiologicheskie i klinicheskie aspekty cherepno-mozgovoj travmy. Dal'nevostochnyj medicinskij zhurnal. 2010;4:125-128. (In Russ.).
  17. Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, A.o.C.P.I.i. Neurology, Spasticity in adults: management using botulinum toxin. National guidelines. London: RCP. 2009/
  18. Nakase-Richardson R, McNamee S, Howe LL, Massengale J, Peterson M, Barnett SD, Harris O, McCarthy M, Tran J, Scott S, Cifu DX. Descriptive characteristics and rehabilitation outcomes in active duty military personnel and veterans with disorders of consciousness with combat- and noncombat-related brain injury. Archives of physical medicine and rehabilitation. 2013;94(10):1861-1869. doi: 10.1016/j.apmr.2013.05.027
  19. Ganesh S, Guernon A, Chalcraft L, Harton B, Smith B, Louise-Bender Pape T. Medical comorbidities in disorders of consciousness patients and their association with functional outcomes. Archives of physical medicine and rehabilitation. 2013;94(10):1899-1907. doi: 10.1016/j.apmr.2012.12.026
  20. Hat'kova CE, Hasanova DR, Korenko LA, Antipova LN, Shperling LP, Popov DV, Pohabov DV, Poznjakova EV. Rezul'taty issledovanija jeffektivnosti odnogo kursa in#ekcij botulinicheskogo toksina tipa A u pacientov s postinsul'tnoj spastichnost'ju verhnej konechnosti ULIS-II: analiz rossijskoj podgruppy pacientov. Zhurnal nevrologii i psihiatrii. im. S.S. Korsakova. 2015;7:89-97. (In Russ.). doi: 10.17116/jnevro20151157189-97
  21. Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. The Lancet. Neurology. 2015;14(10):992-1001. doi: 10.1016/s1474-4422(15)00216-1
  22. Chernikova LA. Vosstanovitel'naja nevrologija: Innovacionnye tehnologii v nejroreabilitacii. Medicinskoe informacionnoe agentstvo. 2016;344. (In Russ.).
  23. Kadykov AS, Chernikova LA, Shahparonova NV. Reabilitacija nevrologicheskih bol'nyh. M.: MEDpress-inform; 2008. (In Russ.).
  24. Bensmail D, Robertson JV, Fermanian C, Roby-Brami A. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements. Neurorehabilitation and neural repair. 2010;24(3):273-281.  doi: 0.1177/1545968309347682
  25. Chernikova LA, Ioffe ME, Kurganskaja ME, Mokienko OA, Kacuba NA, Ustinova KI, Prokopenko RA, Frolov AA. Primenenie tehnologii virtual'noj real'nosti pri vosstanovlenii dvizhenij v paretichnoj ruke u bol'nyh, perenesshih insul't. Fizioterapija, bal'neologija i reabilitacija. 2011;3:3-7. (In Russ.).
  26. Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. Journal of neurology, neurosurgery, and psychiatry. 2009;80(4):380-385.  doi: 10.1136/jnnp.2008.159657
  27. Frolov AA, Mokienko OA, Ljukmanov RH, Chernikova LA, Kotov SV, Turbina LG, Bobrov PD, Birjukova EV, Kondur AA, Ivanova GE, Staricyn AN, Bushkova JuV, Dzhalagonija IZ, Kurganskaja ME, Pavlova OG, Budilin SJu, Aziatskaja GA, Hizhnikova AE, Chervjakov AV, Luk'janov AL, Nadarejshvili GG. Predvaritel'nye rezul'taty kontroliruemogo issledovanija jeffektivnosti tehnologii IMK-jekzoskelet pri postinsul'tnom pareze ruki. Vestnik RGMU. 2016;2:17-25. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.